These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7987822)

  • 21. Treatment of human cells with N-Nitroso(acetoxymethyl)methylamine: distribution patterns of piperidine-sensitive DNA damage at the nucleotide level of resolution are related to the sequence context.
    Cloutier JF; Drouin R; Castonguay A
    Chem Res Toxicol; 1999 Sep; 12(9):840-9. PubMed ID: 10490506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
    Anthoney DA; McIlwrath AJ; Gallagher WM; Edlin AR; Brown R
    Cancer Res; 1996 Mar; 56(6):1374-81. PubMed ID: 8640828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
    lizuka N; Miyamoto K; Tangoku A; Hayashi H; Hazama S; Yoshino S; Yoshimura K; Hirose K; Yoshida H; Oka M
    Br J Cancer; 2000 Nov; 83(9):1209-15. PubMed ID: 11027435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of MutS ATP-dependent functional activities by DNA containing a cisplatin compound lesion (base damage and mismatch).
    Sedletska Y; Fourrier L; Malinge JM
    J Mol Biol; 2007 May; 369(1):27-40. PubMed ID: 17400248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humans and chimpanzees differ in their cellular response to DNA damage and non-coding sequence elements of DNA repair-associated genes.
    Weis E; Galetzka D; Herlyn H; Schneider E; Haaf T
    Cytogenet Genome Res; 2008; 122(2):92-102. PubMed ID: 19096204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.
    Budiman ME; Alexander RW; Bierbach U
    Biochemistry; 2004 Jul; 43(26):8560-7. PubMed ID: 15222767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
    Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
    Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute and chronic cyclophosphamide treatment on meiotic progression and the induction of DNA double-strand breaks in rat spermatocytes.
    Aguilar-Mahecha A; Hales BF; Robaire B
    Biol Reprod; 2005 Jun; 72(6):1297-304. PubMed ID: 15673603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
    Chen G; Zeller WJ
    Anticancer Res; 1993; 13(1):219-23. PubMed ID: 8476216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor efficacy and molecular mechanism of TLK58747, a novel DNA-alkylating prodrug.
    Xu H; Wang Z; Donaldson JC; Yao H; Zhou S; Kelson AB; Ma W; Weber KT; Laborde E; Cheng M; Sambucetti L; Keck JG
    Anticancer Res; 2009 Oct; 29(10):3845-55. PubMed ID: 19846918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of blocking lesions at identical DNA sequences by the nitrosourea and platinum classes of anticancer drugs.
    Gralla JD; Sasse-Dwight S; Poljak LG
    Cancer Res; 1987 Oct; 47(19):5092-6. PubMed ID: 3040238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects.
    Bhuyan BK; Smith KS; Adams EG; Wallace TL; Von Hoff DD; Li LH
    Cancer Chemother Pharmacol; 1992; 30(5):348-54. PubMed ID: 1505072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction.
    Lee CS; Pfeifer GP; Gibson NW
    Biochemistry; 1994 May; 33(19):6024-30. PubMed ID: 8180230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cis-diamminedichloroplatinum(II) adducts in DNA from drug-treated human cell nuclei.
    Bubley GJ; Ashburner BP; Balk SP; Ara G; Varshaney A; Teicher BA
    Biotechniques; 1992 May; 12(5):694, 696, 698. PubMed ID: 1515136
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro evaluation of a novel chemotherapeutic agent, Adozelesin, in gynecologic-cancer cell lines.
    Nguyen HN; Sevin BU; Averette H; Perras J; Hightower R; Ramos R; Donato D; Penalver M
    Cancer Chemother Pharmacol; 1992; 30(1):37-42. PubMed ID: 1586978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of DNA damage responses by adozelesin is S phase-specific and dependent on active replication forks.
    Liu JS; Kuo SR; Beerman TA; Melendy T
    Mol Cancer Ther; 2003 Jan; 2(1):41-7. PubMed ID: 12533671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting critical regions in genomic DNA with AT-specific anticancer drugs.
    Woynarowski JM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):300-8. PubMed ID: 12084472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in in vivo and in vitro sequence-specific sites of cisplatin-DNA adduct formation and detection of a dose-response relationship.
    Bubley GJ; Teicher BA; Ogata GK; Sandoval LS; Kusumoto T
    Biochem Pharmacol; 1994 Jul; 48(1):145-53. PubMed ID: 8043016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymerase chain reaction analysis of cisplatin-induced mitochondrial DNA damage in human ovarian carcinoma cells.
    Daoud SS; Clements MK; Small CL
    Anticancer Drugs; 1995 Jun; 6(3):405-12. PubMed ID: 7670138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different DNA lesions trigger distinct cell death responses in HCT116 colon carcinoma cells.
    Bai S; Goodrich DW
    Mol Cancer Ther; 2004 May; 3(5):613-9. PubMed ID: 15141019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.